Ofev
Nintedanib · Boehringer Ingelheim Pharmaceuticals, Inc.
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Ofev ingredients
| Active ingredient | Strength |
|---|---|
| Nintedanib Esylate | 100 mg/1, 150 mg/1 |
What Ofev is used for
Ofev is a cancer medicine (kinase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Ofev
- Generic name
- Nintedanib
- Made by
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Forms
- Capsule
- Given
- Oral
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA205832
- On the US market since
- 2014
Official information
- Ofev prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Nintedanib)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Ofev?
Ofev (Nintedanib) is a cancer medicine made by Boehringer Ingelheim Pharmaceuticals, Inc., approved by the US FDA.
What are the ingredients of Ofev?
Ofev contains Nintedanib Esylate (100 mg/1, 150 mg/1).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA